[go: up one dir, main page]

MXPA03005510A - Composiciones y metodos para tratar hiperpigmentacion. - Google Patents

Composiciones y metodos para tratar hiperpigmentacion.

Info

Publication number
MXPA03005510A
MXPA03005510A MXPA03005510A MXPA03005510A MXPA03005510A MX PA03005510 A MXPA03005510 A MX PA03005510A MX PA03005510 A MXPA03005510 A MX PA03005510A MX PA03005510 A MXPA03005510 A MX PA03005510A MX PA03005510 A MXPA03005510 A MX PA03005510A
Authority
MX
Mexico
Prior art keywords
treating
methods
compositions
clofibrate
preventing
Prior art date
Application number
MXPA03005510A
Other languages
English (en)
Inventor
Ptchelintsev Dmitri
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of MXPA03005510A publication Critical patent/MXPA03005510A/es
Publication of MX246293B publication Critical patent/MX246293B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Se proporciona una composicion topica para tratar, prevenir o aliviar la hiperpigmentacion en la piel humana. La composicion tiene un agente para despigmentacion en una cantidad efectiva para reducir o disminuir la pigmentacion en un area de la piel a la cual se aplica y un vehiculo cosmetica o farmaceuticamente aceptable. Los agentes para despigmentacion adecuados incluyen acido 3,3'- tiodipropionico, acido tiazolidin-2-carboxilico, kaempferol- 7-glucosido, aceite de semilla de perilla y clofibrato y analogos y derivados de clofibrato. Tambien se proporcionan metodos para tratar, prevenir o aliviar la hiperpigmentacion en la piel humana.
MXPA03005510 2000-12-20 2001-12-14 Composiciones y metodos para tratar hiperpigmentacion. MX246293B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/741,383 US6562321B2 (en) 2000-12-20 2000-12-20 Compositions and methods for treating hyperpigmentation
PCT/US2001/048382 WO2002049580A1 (en) 2000-12-20 2001-12-14 Compositions and methods for treating hyperpigmentation

Publications (2)

Publication Number Publication Date
MXPA03005510A true MXPA03005510A (es) 2004-04-20
MX246293B MX246293B (es) 2007-06-08

Family

ID=24980507

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005510 MX246293B (es) 2000-12-20 2001-12-14 Composiciones y metodos para tratar hiperpigmentacion.

Country Status (9)

Country Link
US (1) US6562321B2 (es)
EP (1) EP1351647B1 (es)
JP (1) JP2004516259A (es)
CN (1) CN1274291C (es)
AU (1) AU2002236626A1 (es)
BR (1) BRPI0116293B1 (es)
CA (1) CA2429935C (es)
MX (1) MX246293B (es)
WO (1) WO2002049580A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020034772A1 (en) 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
US6562321B2 (en) * 2000-12-20 2003-05-13 Avon Products, Inc. Compositions and methods for treating hyperpigmentation
US20040067245A1 (en) * 2000-12-20 2004-04-08 Harish Mahalingam Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
US20040126351A1 (en) * 2002-12-26 2004-07-01 Avon Products, Inc. Topical composition having natural skin anti-irritant ingredient and method of use
US20040242501A1 (en) * 2003-03-20 2004-12-02 Gross Richard A. Spermicidal and virucidal properties of various forms of sophorolipids
US7504385B2 (en) * 2003-12-17 2009-03-17 Avon Products, Inc. si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
US7429391B2 (en) * 2004-01-30 2008-09-30 Access Business Group International Llc Holistic composition and method for reducing skin pigmentation
US20050226899A1 (en) * 2004-04-08 2005-10-13 Mauro Castiglioni Cosmetic mask composition
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
US20090092561A1 (en) * 2007-10-09 2009-04-09 Lupia Joseph A Body-care and household products and compositions comprising specific sulfur-containing compounds
FR2928835B1 (fr) * 2008-03-20 2010-05-07 Nuxe Lab Composition depigmentante a base de crocus sativus.
WO2011025635A2 (en) * 2009-08-31 2011-03-03 Avon Products, Inc. Cosmetic uses of modified stressed yeast extracts and related compositions
US8329149B2 (en) 2009-12-30 2012-12-11 Avon Products, Inc. Topical lightening composition and uses thereof
CN102078486B (zh) * 2011-01-21 2012-06-20 吉林紫鑫药物研究有限公司 一种祛黄褐斑的药物组合物及其制备方法
US9023327B2 (en) * 2012-08-30 2015-05-05 Avon Products, Inc. DICKKOPF-1 expression modulating compositions and uses thereof
BR112015020196B1 (pt) * 2013-03-12 2020-09-29 Avon Products, Inc. Composição tópica para reduzir a pigmentação na pele humana e método de redução da pigmentação na pele humana
WO2015187417A1 (en) * 2014-06-02 2015-12-10 Avon Products, Inc. Topical lightening composition and methods of use thereof
ES2839503T3 (es) * 2016-05-29 2021-07-05 Scientis Sa Uso de derivados de tiofosfato como agentes despigmentantes de la piel

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1000724A6 (fr) 1987-05-20 1989-03-21 Stiefel Lab Ltd Compositions a base de dithranol.
FR2639828B1 (fr) 1988-12-01 1993-11-05 Lvmh Recherche Utilisation du kaempferol et de certains de ses derives pour la preparation d'une composition cosmetique ou pharmaceutique
JP2884466B2 (ja) * 1993-12-27 1999-04-19 長瀬産業株式会社 シソ抽出液、その製造方法およびそれを含有する美白化粧料
WO1996007396A2 (en) * 1994-09-07 1996-03-14 Johnson & Johnson Consumer Products, Inc. Retinoid compositions
FR2742750B1 (fr) 1995-12-22 1998-01-30 Oreal Nouveaux derives de l'acide l-2-oxothiazolidine 4-carboxylique et leur utilisation pour le soin de la peau
FR2773323B1 (fr) 1998-01-05 2000-02-11 Oreal Composition contenant une association de procysteine et de polyol
FR2778561B1 (fr) 1998-05-14 2001-04-20 Oreal Azurants optiques comme agents blanchissants
TW591026B (en) 1998-06-23 2004-06-11 Upjohn Co Inhibitors of alpha4beta1 mediated cell adhesion
DE19829789A1 (de) 1998-07-03 2000-01-05 Beiersdorf Ag Gegen Akne und entzündete Comedonen wirksame Zubereitungen enthaltend Serin-Proteasen und ein oder mehrere Calciumsalze
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6087385A (en) * 1998-10-30 2000-07-11 University Of Mississippi Flavonoid derivatives
DE19929511C2 (de) * 1999-06-29 2003-04-10 Cognis Deutschland Gmbh Hochkonzentriert fließfähige Aniontensidmischungen
CA2413919A1 (en) * 2000-03-21 2001-09-13 Avon Products, Inc. Methods using phytol to improve the appearance of skin and compositions for such methods
US6562321B2 (en) * 2000-12-20 2003-05-13 Avon Products, Inc. Compositions and methods for treating hyperpigmentation

Also Published As

Publication number Publication date
EP1351647A4 (en) 2005-03-16
CA2429935C (en) 2011-03-15
WO2002049580A1 (en) 2002-06-27
MX246293B (es) 2007-06-08
JP2004516259A (ja) 2004-06-03
EP1351647B1 (en) 2012-11-14
BR0116293A (pt) 2004-08-17
BRPI0116293B1 (pt) 2016-07-12
EP1351647A1 (en) 2003-10-15
US6562321B2 (en) 2003-05-13
AU2002236626A1 (en) 2002-07-01
CN1274291C (zh) 2006-09-13
CA2429935A1 (en) 2002-06-27
CN1482892A (zh) 2004-03-17
US20020141953A1 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
MXPA03005510A (es) Composiciones y metodos para tratar hiperpigmentacion.
TW200505490A (en) Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
AR025071A1 (es) Aditivo para mejorar la resistencia al agua de formulaciones cosmeticas o dermatologicas
US6319942B1 (en) Topical scar treatments using alkanolamines
WO2002069963A3 (en) Compositions comprising ferulic acid, caffeic acid, tannic acid or ellagic acid and their use for the preparation of a medicament for the treatment of dermatological disorders
ES2129013A1 (es) Utilizacion de la vitamina c o de sus derivados o analogos para estimular la sintesis de la elastina cutanea.
WO2002019981A3 (en) Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
EP0937453A3 (en) Cosmetic and tissue cleansing and moisturizing composition
BR0107869A (pt) Composições farmacêuticas eletrogiradas
EP1859835A3 (en) Topical agent for dermatological use containing 4-hydroxyphenyl-alpha-D-glucopyranoside
MX249762B (es) Acidos aldonicos de oligosacarido y su uso topico.
ATE222748T1 (de) Orale zusammensetzung mit verbesserter aufnahme
AR049829A1 (es) Procedimiento y composiciones utiles para prevenir y/o tratar las pieles sensibles y/o secas
WO2001060331A3 (en) Compositions for preventing cellulite in mammalian skin
AU2002361265A1 (en) Pharmaceutical composition for the treatment of psoriasis and other skin diseases
EP1074245A3 (en) Composition using mineral salts for therapeutic treatment
BR0313370A (pt) composição despigmentante para a pele, uso de uma composição despigmentante para a pele, uso cosmético da mesma e método para um tratamento cosmético não terapêutico para embelezar a pele
BRPI0406832A (pt) Método de reduzir o crescimento de pêlos em um ser humano, uso de um conjugado de alfa-difluorometilornitina ou um sal farmaceuticamente aceitável do mesmo, composto, composição, e, uso de um composto
FR2651434B1 (fr) Composition d'acides desoxyribonucleiques depolymerises pour usage local dans les traitements cosmetiques de la peau et du corps.
WO2003039453A3 (en) Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
CO4900082A1 (es) Composiciones cosmeticas para aplicacion topica en la piel y/o brillante de la piel, que contienen extracto de corteza de sauce.
MXPA04001289A (es) Composicion cosmetica y metodo para tratar la piel.
DE69717311D1 (de) Kosmetische, dermatologische und pharmazeutische anwendung eines terminalia catappa pflanzenextrakts
KR970703142A (ko) 신전성 선조를 치료하기 위해 알파 히드록시산을 도포시키는 방법(applying alpha hydroxy acids for striae distensae)
RU2004119850A (ru) Композиция на основе сложного диосгенина для топического нанесения

Legal Events

Date Code Title Description
FG Grant or registration